2188 Attain |
Product Characteristics | |||
|---|---|---|---|---|
| US Market Release | Aug-01 | Serial Number Prefix | LEB | |
| Registered US Implants | 1,800 | Type and/or Fixation | Transvenous, Coronary Sinus/ Cardiac Vein, Canted |
|
| Estimated Active US Implants | 400 | Polarity | Bipolar | |
| Advisories | None | Steroid | No | |
| System Longevity Study Results |
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Leads Enrolled in Study | 14 | |||||||||
| Cumulative Months of Follow-Up | 383 | |||||||||
| Number of Leads Active in Study | 1 | |||||||||
| Qualifying Complications | 1 Total | |||||||||
| Extra Cardiac Stimulation | 1 | |||||||||
